These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37927030)

  • 21. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric antigen receptor T-cell therapy for HIV cure.
    Alfageme-Abello O; Porret R; Perreau M; Perez L; Muller YD
    Curr Opin HIV AIDS; 2021 Mar; 16(2):88-97. PubMed ID: 33560017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4
    Amand M; Adams P; Schober R; Iserentant G; Servais JY; Moutschen M; Seguin-Devaux C
    Elife; 2023 Feb; 12():. PubMed ID: 36800238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering CAR T Cells to Target the HIV Reservoir.
    Mu W; Carrillo MA; Kitchen SG
    Front Cell Infect Microbiol; 2020; 10():410. PubMed ID: 32903563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fight fire with fire: Gene therapy strategies to cure HIV.
    Huyghe J; Magdalena S; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2017 Aug; 15(8):747-758. PubMed ID: 28692305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
    Liu D; Tian S; Zhang K; Xiong W; Lubaki NM; Chen Z; Han W
    Protein Cell; 2017 Dec; 8(12):861-877. PubMed ID: 28488245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.
    Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in HIV-1-specific chimeric antigen receptor cells to target the HIV-1 reservoir.
    Choudhary MC; Cyktor JC; Riddler SA
    J Virus Erad; 2022 Jun; 8(2):100073. PubMed ID: 35784676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy.
    Hauser JR; Hong H; Babady NE; Papanicolaou GA; Tang YW
    J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31694968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of CAR-T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment.
    Adabi N; Pordel S; Rezaee MA; Shobeiri FS; Shobeiri SS
    J Gene Med; 2023 May; 25(5):e3484. PubMed ID: 36781390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-Resistant and HIV-Specific CAR-Modified CD4
    Maldini CR; Gayout K; Leibman RS; Dopkin DL; Mills JP; Shan X; Glover JA; Riley JL
    Mol Ther; 2020 Jul; 28(7):1585-1599. PubMed ID: 32454027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical and clinical studies of CAR-NK-cell therapies for malignancies.
    Li H; Song W; Li Z; Zhang M
    Front Immunol; 2022; 13():992232. PubMed ID: 36353643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
    Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
    Front Immunol; 2018; 9():492. PubMed ID: 29616024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 Cure.
    Maina EK; Adan AA; Mureithi H; Muriuki J; Lwembe RM
    Curr HIV Res; 2021; 19(1):14-26. PubMed ID: 32819259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo.
    Maldini CR; Claiborne DT; Okawa K; Chen T; Dopkin DL; Shan X; Power KA; Trifonova RT; Krupp K; Phelps M; Vrbanac VD; Tanno S; Bateson T; Leslie GJ; Hoxie JA; Boutwell CL; Riley JL; Allen TM
    Nat Med; 2020 Nov; 26(11):1776-1787. PubMed ID: 32868878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
    Marofi F; Rahman HS; Al-Obaidi ZMJ; Jalil AT; Abdelbasset WK; Suksatan W; Dorofeev AE; Shomali N; Chartrand MS; Pathak Y; Hassanzadeh A; Baradaran B; Ahmadi M; Saeedi H; Tahmasebi S; Jarahian M
    Stem Cell Res Ther; 2021 Aug; 12(1):465. PubMed ID: 34412685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for enhancing CAR T cell expansion and persistence in HIV infection.
    Rothemejer FH; Lauritsen NP; Søgaard OS; Tolstrup M
    Front Immunol; 2023; 14():1253395. PubMed ID: 37671164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.